EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of T and B lymphocyte cannabinoid type 1 and 2 receptors in major depression and suicidal behaviours

Michael Maes iD, Muanpetch Rachayon, Ketsupar Jirakran, Atapol Sughondhabirom, Abbas F Almulla iD, Pimpayao Sodsai

Acta Neuropsychiatrica · 2024

DOI: 10.1017/neu.2023.35 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropsychiatrica, 2024. Verfasst von Michael Maes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2, B-Lymphocytes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early flow cytometry studies revealed T cell activation in major depressive disorder (MDD). MDD is characterised by activation of the immune-inflammatory response system (IRS) and the compensatory immunoregulatory system (CIRS), including deficits in T regulatory (Treg) cells. This study examines the number of cannabinoid type 1 (CB1) and type 2 (CB2) receptor-bearing T/B lymphocytes in MDD, and the effects of in vitro cannabidiol (CBD) administration on CB1/CB2-bearing immunocytes. Using flow cytometry, we determined the percentage of CD20+CB2+, CD3+CB2+, CD4+CB2+, CD8+CB2+ and FoxP3+CB1+ cells in 19 healthy controls and 29 MDD patients in 5 conditions: baseline, stimulation with anti-CD3/CD28 with or without 0.1 µg/mL, 1.0 µg/mL, or 10.0 µg/mL CBD. CB2+ was significantly higher in CD20+ than CD3+ and CD4+ and CD 8+ cells. Stimulation with anti-CD3/CD8 increases the number of CB2-bearing CD3+, CD4+ and CD8+ cells, as well as CB1-bearing FoxP3+ cells. There was an inverse association between the number of reduced CD4+ CB2+ and IRS profiles, including M1 macrophage, T helper-(Th)-1 and Th-17 phenotypes. MDD is characterised by lowered basal FoxP3+ CB1+% and higher CD20+ CB2+%. 33.2% of the variance in the depression phenome (including severity of depression, anxiety and current suicidal behaviours) is explained by CD20+ CB2+ % (positively) and CD3+ CB2+% (inversely). All five immune cell populations were significantly increased by 10 µg/mL of CBD administration. Reductions in FoxP3+ CB1+% and CD3+ /CD4+ CB2+% contribute to deficits in immune homoeostasis in MDD, while increased CD20+CB2+% may contribute to the pathophysiology of MDD by activating T-independent humoral immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2B-LymphocytesHumansFemaleMaleAdultMiddle AgedCannabidiolSuicidal IdeationT-LymphocytesYoung AdultCase-Control Studies

Stichwörter der Autor:innen

Major depressioncytokinesinflammationmood disordersneuroimmunepsychoneuroimmunology

Substanzen

Receptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Cannabidiol

Autor:innen und Institutionen

  • Department of Psychiatry, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
  • Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China,Chengdu610072, China.
  • Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria.
  • Research Institute, Medical University Plovdiv, Plovdiv, Bulgaria.
  • Kyung Hee University, Seoul, Korea.
  • Department of Pediatrics, Faculty of Medicine, Maximizing Thai Children's Developmental Potential Research Unit, Chulalongkorn University, Bangkok, Thailand.

ORCID-Profile: Michael Maes, Abbas F Almulla

Zitieren

APA

Maes, M., Rachayon, M., Jirakran, K., Sughondhabirom, A., Almulla, A. F., & Sodsai, P. (2024). Role of T and B lymphocyte cannabinoid type 1 and 2 receptors in major depression and suicidal behaviours. Acta Neuropsychiatrica. https://doi.org/10.1017/neu.2023.35

Vancouver

Maes M, Rachayon M, Jirakran K, Sughondhabirom A, Almulla AF, Sodsai P. Role of T and B lymphocyte cannabinoid type 1 and 2 receptors in major depression and suicidal behaviours. Acta Neuropsychiatrica. 2024. doi:10.1017/neu.2023.35

BibTeX
@article{Maes2024,
  author = {Maes, Michael and Rachayon, Muanpetch and Jirakran, Ketsupar and Sughondhabirom, Atapol and Almulla, Abbas F and Sodsai, Pimpayao},
  title = {Role of T and B lymphocyte cannabinoid type 1 and 2 receptors in major depression and suicidal behaviours},
  journal = {Acta Neuropsychiatrica},
  year = {2024},
  doi = {10.1017/neu.2023.35}
}
Kostenlos starten →